Pharmacokinetic considerations for therapies used to treat interstitial cystitis-Reference-Cited by-同舟云学术

Pharmacokinetic considerations for therapies used to treat interstitial cystitis

Published:2014-03-12 Issue:5 Volume:10 Page:673-684
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Gardella Barbara,Porru Daniele,Allegri Massimo,Bogliolo Stefano,Iacobone Anna Daniela,Minella Cristina,Nappi Rossella Elena,Ferrero Simone,Spinillo Arsenio

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425255.2014.896338

Reference96 articles.

1. Diagnostic Criteria, Classification, and Nomenclature for Painful Bladder Syndrome/Interstitial Cystitis: An ESSIC Proposal

2. Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis

3. Chronic Pelvic Pain as a Form of Complex Regional Pain Syndrome

4. Neuropeptides in Lower Urinary Tract Function

5. Afferent Mechanism in the Urinary Tract

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PTHR1 in Bone;GPCRs as Therapeutic Targets;2022-09-16

2. Cultured versus freshly isolated adipose-derived stem cells in improvement of the histopathological outcomes in HCL-induced cystitis in a rat model;Biomedicine & Pharmacotherapy;2022-09

3. Botulinum Toxin Therapy for Pelvic and Urogenital Pain;Botulinum Toxin Treatment of Pain Disorders;2022

4. Bladder Surface Mucin Analogues;Urological and Gynaecological Chronic Pelvic Pain;2017

5. Pelvic and Urogenital Pain;Botulinum Toxin Treatment of Pain Disorders;2015